I am accumulating while waiting
1. baxter /grifols taking out momenta after new sivig/sfc data
2) momenta already shifted focus from the enoxaparin quagmire, the followup patents
will be more ironclad
3) for more nonsensical favoritism filed against woodcock when m-glatiramer gets the nod
4) when amphastar-watson fubar srouce tainted batches of heparin (like baxter), to see their science (or lack thereof) in resolving the situation
Sentiment: Hold